As the U.S. government intensifies efforts to acquire Greenland, President Donald Trump has responded to European pushback ...
With star checkpoint inhibitors like Keytruda and Opdivo now sporting subcutaneous formulations, GSK has struck a deal aimed ...
After a series of headcount reductions in recent years, Takeda has disclosed a new round of cuts expected to affect ...
The New York powerhouse has agreed to surrender its 11.7% interest in the HIV-focused company for $1.875 billion. Under terms ...
The U.S. Supreme Court has decided to hear a case between Amarin Pharma and generic drugmaker Hikma that puts so-called ...
Amid a viral social media trend glorifying the halcyon days of 2016, Novo Nordisk has gone back an extra decade to find ...
The “Rerouting Minds” webpage comprises information about LSD’s clinical history dating back to the 1930s, about how ...
Prefilled drug delivery device specialist Apiject has signed a lease for a new site in Apex, North Carolina, that will house ...
With an FDA accelerated approval in November 2023, Ixchiq became the world’s first shot for chikungunya. Its retreat leaves Bavarian Nordic’s Vimkunya the only available chikungunya vaccine in the U.S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback